AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34763914 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf health plan (INT)
Number of subjects: 3593
Study 34763914 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 3593
Study 33907131 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphygmomanometer (group A)
Number of subjects: 120
Study 33907131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet (group B)
Number of subjects: 120
Study 33907131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no blocking)
Number of subjects: 120
Study 34252573 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV negative women
Number of subjects: 2767
Study 34252573 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive women
Number of subjects: 2767
Study 34252573 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-negative women
Number of subjects: 2767
Study 32401072 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance/movement therapy (DMT)
Number of subjects: 31
Study 32401072 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 31
Study 32781920 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperate environment (18.3°C)
Number of subjects: 12
Study 32781920 — intervention group
Group type: COMPARATOR
Intervention: Hot environment (36.3°C)
Number of subjects: 12
Study 34315418 — intervention group
Group type: EXPERIMENTAL
Intervention: Scent dog detection of non-inactivated saliva samples
Number of subjects: 10
Study 34315418 — intervention group
Group type: EXPERIMENTAL
Intervention: Scent dog detection of urine samples
Number of subjects: 10
Study 34315418 — intervention group
Group type: EXPERIMENTAL
Intervention: Scent dog detection of sweat samples
Number of subjects: 10
Study 34315418 — intervention group
Group type: EXPERIMENTAL
Intervention: Scent dog detection of saliva samples
Number of subjects: 10
Study 33319537 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA) in the first stage and unicompartmental knee arthroplasty (UKA) in the second stage (observation group)
Number of subjects: 24
Study 33319537 — intervention group
Group type: COMPARATOR
Intervention: Bilateral TKAs (control group)
Number of subjects: 24
Study 35680431 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 259
Study 35680431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 34217660 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-optimized CRT (NON-OPT group; n=89)
Number of subjects: 180
Study 34217660 — intervention group
Group type: COMPARATOR
Intervention: Electrocardiographically optimized CRT based on the fusion-optimized intervals (FOI group; n=91)
Number of subjects: 180
Study 34061470 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300
Study 34061470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 34266844 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA) monotherapy with sham photodynamic therapy (n=80)
Number of subjects: 160
Study 34266844 — intervention group
Group type: COMPARATOR
Intervention: Aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) (n=80)
Number of subjects: 160
Study 34266844 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study 33191854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model integrated with inflammation-based factors
Number of subjects: 887
Study 35188081 — intervention group
Group type: EXPERIMENTAL
Intervention: BADS-C total score
Number of subjects: 74
Study 35188081 — intervention group
Group type: EXPERIMENTAL
Intervention: Key Search Test
Number of subjects: 74
Study 35188081 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoo Map Test 1
Number of subjects: 74
Study 35188081 — intervention group
Group type: EXPERIMENTAL
Intervention: BADS-C subtests
Number of subjects: 74
Study 35188081 — intervention group
Group type: EXPERIMENTAL
Intervention: BADS-C total score, Key Search Test, Zoo Map Test 1
Number of subjects: 74
Study 34229860 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.5 mcg.kg‐1 (Group F)
Number of subjects: 124
Study 34229860 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 124
Study 32353057 — intervention group
Group type: EXPERIMENTAL
Intervention: R Shiny for implementing customizable surveys
Number of subjects: 0
Study 35440941 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nursing model of medical care
Number of subjects: 120
Study 35440941 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 120
Study 34288617 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired respondent data from the Canadian Health Measures Survey (CHMS)
Number of subjects: 0
Study 34952447 — intervention group
Group type: EXPERIMENTAL
Intervention: Active anodal HD-tDCS
Number of subjects: 37
Study 34952447 — intervention group
Group type: COMPARATOR
Intervention: Sham anodal HD-tDCS
Number of subjects: 37
Study 33166032 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis tablets at a dose of 250 mg twice daily for 4 months
Number of subjects: 54
Study 33166032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 35932536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm olein (IV64)
Number of subjects: 40
Study 35932536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa butter (CB)
Number of subjects: 40
Study 35932536 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO)
Number of subjects: 40
Study 35932536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm olein (PO)
Number of subjects: 40
Study 32228663 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment added to standard limb hygiene for six weeks
Number of subjects: 1800
Study 32228663 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment added to standard limb hygiene for six weeks
Number of subjects: 1800
Study 34753083 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive control treatment
Number of subjects: 44
Study 32768403 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) at 660 nm, 100 mW, 6 seconds, 2 J/cm2
Number of subjects: 20
Study 32768403 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (DXM) 4 mg every 8 hours for 3 days
Number of subjects: 20
Study 32768403 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 20
Study 32768403 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (DXM)
Number of subjects: 20
Study 34791669 — intervention group
Group type: EXPERIMENTAL
Intervention: Bouldering psychotherapy (BPT)
Number of subjects: 156
Study 34791669 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 156
Study 32781913 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft shoe
Number of subjects: 848
Study 32781913 — intervention group
Group type: COMPARATOR
Intervention: Hard shoe
Number of subjects: 848
Study 35525050 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 156
Study 35525050 — intervention group
Group type: COMPARATOR
Intervention: Control (no VR)
Number of subjects: 156
Study 34430349 — intervention group
Group type: EXPERIMENTAL
Intervention: H1299 lung cancer cell lysates (10 mg protein/vaccine) with Iscomatrix™ adjuvant via deep intradermal injection q 4 weeks ×6
Number of subjects: 21
Study 34430349 — intervention group
Group type: EXPERIMENTAL
Intervention: H1299 lung cancer cell lysates with Iscomatrix™ adjuvant
Number of subjects: 21
Study 34430349 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide/celecoxib
Number of subjects: 21
Study 32516765 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender oil (steam inhalation)
Number of subjects: 57
Study 32516765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 35570237 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA)
Number of subjects: 943
Study 35570237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 943
Study 32171318 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 360
Study 32171318 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 360
Study 32171318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild moxibustion
Number of subjects: 360
Study 32171318 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-needling
Number of subjects: 360
Study 32171318 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 360
Study 32171318 — intervention group
Group type: COMPARATOR
Intervention: Celebrex treatment
Number of subjects: 360
Study 32171318 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 360
Study 36293867 — intervention group
Group type: EXPERIMENTAL
Intervention: KDL Active School Plan (KDL-ASP)
Number of subjects: 596
Study 36293867 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical activities
Number of subjects: 596
Study 33615328 — intervention group
Group type: EXPERIMENTAL
Intervention: RY Stop
Number of subjects: 499
Study 33615328 — intervention group
Group type: COMPARATOR
Intervention: TR Band
Number of subjects: 499
Study 33681738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg followed by misoprostol 400 μg
Number of subjects: 351
Study 33681738 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by misoprostol 400 μg
Number of subjects: 351
Study 33681738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg
Number of subjects: 351
Study 33681738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 33183274 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilisation with movement (MWM) combined with exercise
Number of subjects: 70
Study 33183274 — intervention group
Group type: COMPARATOR
Intervention: Sham MWM combined with exercise
Number of subjects: 70
Study 35852859 — intervention group
Group type: EXPERIMENTAL
Intervention: FDM 3D-printed surgical guide
Number of subjects: 28
Study 35852859 — intervention group
Group type: COMPARATOR
Intervention: Stereolithographic guide
Number of subjects: 28
Study 34414979 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact aerobics programme supplemented by pelvic floor muscle training for 6 weeks
Number of subjects: 32
Study 34414979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 33752696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular magnetic resonance (CMR) imaging
Number of subjects: 51
Study 33752696 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress-perfusion CMR
Number of subjects: 51
Study 33752696 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR for diagnosing acute coronary syndrome (ACS)
Number of subjects: 51
Study 35943928 — intervention group
Group type: EXPERIMENTAL
Intervention: FASD (force-activated separation device)
Number of subjects: 367
Study 35943928 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FASD)
Number of subjects: 367
Study 35943928 — intervention group
Group type: EXPERIMENTAL
Intervention: FASD
Number of subjects: 367
Study 34229364 — intervention group
Group type: EXPERIMENTAL
Intervention: DEHP-containing infusion sets warmed with blood-fluid warmers
Number of subjects: 30
Study 34229364 — intervention group
Group type: COMPARATOR
Intervention: DEHP-free infusion sets warmed with blood-fluid warmers
Number of subjects: 30
Study 32568220 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radical left pancreatectomy (LRLP)
Number of subjects: 1
Study 36129364 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk ’n Watch protocol
Number of subjects: 195
Study 34091804 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 99
Study 34091804 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM) protocol
Number of subjects: 99
Study 32679728 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 g/h carbohydrate intake (HIGH)
Number of subjects: 26
Study 32679728 — intervention group
Group type: COMPARATOR
Intervention: 90 g/h carbohydrate intake (MED)
Number of subjects: 26
Study 32679728 — intervention group
Group type: COMPARATOR
Intervention: 60 g/h carbohydrate intake (LOW)
Number of subjects: 26
Study 36199067 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 0
Study 36199067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34044633 — intervention group
Group type: EXPERIMENTAL
Intervention: BCL2 polymorphisms and IL19 SNP rs2243188
Number of subjects: 150
Study 34044633 — intervention group
Group type: EXPERIMENTAL
Intervention: BCL2 and IL19 susceptibility alleles
Number of subjects: 150
Study 32055002 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation with cixutumumab
Number of subjects: 210
Study 32055002 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation alone (Control)
Number of subjects: 210
Study 32055002 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk disease
Number of subjects: 210
Study 32055002 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume disease
Number of subjects: 210
Study 32055002 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA >0.2 to ≤4.0 ng/mL
Number of subjects: 210
Study 32055002 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA >4.0 ng/mL
Number of subjects: 210
Study 35995418 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic treatment (Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium lactis, 32 billion colony forming units per day plus 3.2 g of inulin)
Number of subjects: 34
Study 33620461 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming (FAW), n=100
Number of subjects: 200
Study 32353101 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative Doppler ultrasound
Number of subjects: 228
Study 32353101 — intervention group
Group type: COMPARATOR
Intervention: Clinical group (no Doppler ultrasound)
Number of subjects: 228
Study 32353101 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound group
Number of subjects: 228
Study 32353101 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 228
Study 616900538 — intervention group
Group type: EXPERIMENTAL
Intervention: Quince syrup (1 tablespoon/TDS) for 1 week
Number of subjects: 76
Study 616900538 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B6 tablets (20mg/TDS) for 1 week
Number of subjects: 76
Study 36145196 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU/day vitamin D supplementation
Number of subjects: 2808
Study 36145196 — intervention group
Group type: EXPERIMENTAL
Intervention: 3200 IU/day vitamin D supplementation
Number of subjects: 2808
Study 33677449 — intervention group
Group type: EXPERIMENTAL
Intervention: rtfMRI Neurofeedback Training (NFT) in addition to standard care
Number of subjects: 52
Study 33677449 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 52
Study 32548286 — intervention group
Group type: EXPERIMENTAL
Intervention: Half stack segmentation method for calculating background parenchymal enhancement (BPE) from DCE-MRI
Number of subjects: 735
Study 32548286 — intervention group
Group type: COMPARATOR
Intervention: Full stack segmentation method for calculating BPE from DCE-MRI
Number of subjects: 735
Study 32548286 — intervention group
Group type: COMPARATOR
Intervention: Center 5 slices segmentation method for calculating BPE from DCE-MRI
Number of subjects: 735
Study 35672955 — intervention group
Group type: EXPERIMENTAL
Intervention: Maralixibat
Number of subjects: 57
Study 35672955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 32270633 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied at Tianding (LI 17), Fengchi (GB 20), and Jiaji (EX-B 2, C3-C5), continuous wave, 10-20 Hz, 30 min each time, once a day, 6 times a week for 4 weeks
Number of subjects: 70
Study 32270633 — intervention group
Group type: COMPARATOR
Intervention: Control group received Xingnao Kaiqiao acupuncture at Neiguan (PC 6), Shuigou (GV 26), Sanyinjiao (SP 6), Jiquan (HT 1), Chize (LU 5), and Weizhong (BL 40), needles sustained for 30 min, same treatment frequency as observation group
Number of subjects: 70
Study 34419039 — intervention group
Group type: EXPERIMENTAL
Intervention: Orodental consultation requests due to dental problems
Number of subjects: 300
Study 34419039 — intervention group
Group type: EXPERIMENTAL
Intervention: Orodental consultation requests due to mucosal problems
Number of subjects: 300
Study 34419039 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and consultation request relationship
Number of subjects: 300
Study 34419039 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to specialist due to oral problems
Number of subjects: 300
Study 32738935 — intervention group
Group type: EXPERIMENTAL
Intervention: live attenuated intranasal pertussis vaccine BPZE1
Number of subjects: 0
Study 32738935 — intervention group
Group type: EXPERIMENTAL
Intervention: maternal immunisation
Number of subjects: 0
Study 34881442 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid surface macro-design implants (HS)
Number of subjects: 40
Study 34881442 — intervention group
Group type: COMPARATOR
Intervention: Conventional implants with moderately rough surface (RS)
Number of subjects: 40
Study 33799064 — intervention group
Group type: EXPERIMENTAL
Intervention: Salix cupularis
Number of subjects: 0
Study 33799064 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsites around Salix cupularis
Number of subjects: 0
Study 34783683 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 100
Study 34783683 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Number of subjects: 100
Study 34783683 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Hypnosis
Number of subjects: 100
Study 34783683 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 32189665 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HW)
Number of subjects: 8
Study 32189665 — intervention group
Group type: COMPARATOR
Intervention: Placebo water (PW)
Number of subjects: 8
Study 35410121 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab
Number of subjects: 1003
Study 34464390 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed ankle joint condition
Number of subjects: 14
Study 34464390 — intervention group
Group type: COMPARATOR
Intervention: Free ankle joint condition
Number of subjects: 14
Study 32160801 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 269
Study 32160801 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily
Number of subjects: 269
Study 32160801 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice daily
Number of subjects: 269
Study 32160801 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 269
Study 36424115 — intervention group
Group type: COMPARATOR
Intervention: Best practice advice (one session of physiotherapy, up to two optional additional advice sessions)
Number of subjects: 61
Study 36424115 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive exercise (up to six sessions of physiotherapy)
Number of subjects: 61
Study 34284552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil IN 0.5 μg kg‐1
Number of subjects: 99
Study 34284552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil IN 0.25 μg kg‐1
Number of subjects: 99
Study 34284552 — intervention group
Group type: COMPARATOR
Intervention: IV midazolam 0.04 mg kg‐1 and IN 0.9% NaCl (placebo)
Number of subjects: 99
Study 35958557 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine long chain omega-3 polyunsaturated fatty acids (1.1 g EPA + 0.8 g DHA daily)
Number of subjects: 0
Study 35958557 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal weight individuals)
Number of subjects: 0
Study 35958557 — intervention group
Group type: COMPARATOR
Intervention: Control group (individuals living with obesity)
Number of subjects: 0
Study 33636027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg) plus ipilimumab (1 mg/kg) without enzalutamide (Cohort 1)
Number of subjects: 30
Study 33636027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg) plus ipilimumab (1 mg/kg) and enzalutamide (Cohort 2)
Number of subjects: 30
Study 32723718 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic nudge delivered via a wrist-worn wearable device
Number of subjects: 20
Study 32723718 — intervention group
Group type: COMPARATOR
Intervention: No haptic nudge
Number of subjects: 20
Study 33839115 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor air quality measurements of volatile organic compounds (VOCs) and inorganic gaseous pollutants using passive samplers over 7 days.
Number of subjects: 5017
Study 33839115 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model for estimating concentrations of VOCs and inorganic gaseous pollutants.
Number of subjects: 5017
Study 33839115 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with indoor VOC and inorganic gaseous pollutant concentrations.
Number of subjects: 5017
Study 33396846 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable cameras capturing snacking episodes
Number of subjects: 158
Study 35580140 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 home visits by a Community Health Worker (CHW) and a scheduled appointment to attend the smoking cessation program at the Public Health System (PHS)
Number of subjects: 328
Study 35580140 — intervention group
Group type: COMPARATOR
Intervention: Scheduled appointment to attend the cessation program at the Public Health System (PHS)
Number of subjects: 328
Study 34289903 — intervention group
Group type: EXPERIMENTAL
Intervention: ResidueFinder
Number of subjects: 0
Study 34289903 — intervention group
Group type: EXPERIMENTAL
Intervention: MutationFinder
Number of subjects: 0
Study 34289903 — intervention group
Group type: EXPERIMENTAL
Intervention: ResidueFinder with streamlined regular expression (cut)
Number of subjects: 0
Study 34289903 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular expressions tested using expanded F‐measure statistics
Number of subjects: 0
Study 35968476 — intervention group
Group type: EXPERIMENTAL
Intervention: Isha yoga practice (3 minutes daily)
Number of subjects: 0